LuceyJFDangmanB. A re-examination of the role of oxygen in retrolental fibroplasia. Pediatrics1984; 73: 82–96
2.
CriswickVGSchepensCL. Familial exudative retinopathy. Am J Ophthalmol1969; 68: 578
3.
GibsonDLShepsSBSchechterMTWigginsSMcCormickAQ. Retinopathy of prematurity: A new epidemic?Pediatrics1989; 83: 486–492
4.
SaitoYOmotoTChoYHatsukawaYFujimuraMTakeuchiT. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefe's Arch Clin Exp Ophthalmol1993; 231: 151–156
5.
CunninghamSFleckBWEltonRAMcIntoshN. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet1995; 346: 1464–1465
6.
PennJSHenryMMTolmanBL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res1994; 36: 724–731
7.
PhelpsDLRosenbaumAL. Effects of marginal hypoxaemia on recovery from oxygen-induced retinopathy in the kitten model. Pediatrics1984; 73: 1–6
8.
ReynaudXDoreyCK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci1994; 35: 3169–3177
9.
American Academy of Pediatrics and American College of Obstetricians and Gynaecologists. Guidelines for perinatal care, 2nd edn. 1988: 247
10.
Report of a BPA working party: Neonatal Resuscitation.London: British Paediatric Association1993
11.
RamjiSRoothGSaugstadOD. Resuscitation of asphyxic newborn infants with room air or 100% oxygen. Pediatr Res1993; 34: 809–812
12.
LundstromKEPrydsOGreisenG. Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Arch Dis Child1995; 73: F81–F86
DeckhardtRStewardDJ. Noninvasive arterial hemoglobin saturation versus transcutaneous oxygen tension monitoring in the preterm infant. Crit Care Med1984; 12: 935
15.
TermoteJUMSchalijDelfosNEWittebolPostDBrouwersHAAHoogervorstBRCatsBP. Surfactant replacement therapy: A new risk factor in developing retinopathy of prematurity?Eur J Pediatr1994; 153: 113–116
16.
PennefatherPMTinWClarkeMPFritzSStrongNP. Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment. Br J Ophthalmol1996; 80: 420–424
17.
HittnerHMGodioLBSpeerME. Rudolph AJ. Retrolenta fibroplasia: Efficacy of vitamin E in a double blind clinical study of preterm infants. N Engl J Med1981; 305: 1365–1371
18.
WattsJLSinclairJCBrackenMB, eds. Effective Care of the Newborn Infant.Oxford: Oxford University Press1992: 26, 617–639
19.
JohnsonLQuinnGEAbbasiSOtisC. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: A controlled clinical trial. J Pediatr1989; 114: 827–838
20.
FinerNNPetersKLHayekZMerkelCL. Vitamin E and necrotizing enterocolitis. Pediatrics1984; 73: 387–393
21.
RosenbaumALPhelpsDLIsenbergSJLeakeRDDoreyF. Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment. Ophthalmology1985; 92: 1012–1014
22.
LakatosLHatvaniIOrozlanGKarmazsinLMatkovicsB. d-Penacillamine in the prevention of retrolental fibroplasia. Acta Paediatr Sci Hung1982; 23: 327–335
23.
RussellGABCookeRWI. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child1995; 73: F27–F31
24.
ShenaiJPKennedyKAChytilFStahlmanMT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr1987; 111: 269–277
25.
LanumJ. The damaging effects of light on the retina. Surv Ophthamol1978; 22: 221–249
26.
StefansonEWolbarshtMLLandersMB. In vivo oxygen consumption in rhesus monkeys in light and dark. Exp Eye Res1983; 37: 251–256
27.
BaertsWDe BlecourtDevileeWildervanck MSauerPJJ. Ambient light, ophthalmic artery blood flow velocities and retinopathy of prematurity. Acta Paediatrica, International Journal of Pediatr1993; 82: 719–722
BossiEKoernerFFluryBZulaufM. Retinopathy of prematurity: A risk factor analysis with univariate and multivariate statistics. Helv Paediatr Acta1984; 39: 307–317
30.
FlowerRWBlakeDA. Retrolental fibroplasia: Evidence for the role of the prostaglandin cascade in the pathogenesis of oxygen-induced retinopathy in the newborn beagle. Pediatr Res1981; 15: 1293–1302
31.
GersonyWMPeckhamGJEllisonRC. Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study. J Pediatr1983; 102: 895–905
32.
YehTFRavalDPyatiSPlidesRS. Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). Prostaglandins1983; 25: 385–391
33.
BohlerTWagnerSSeiberthVLinderkampO. Blood rheology and retinopathy in premature infants with very low birth weight. Clin Hemorheol1995; 15: 305–309
34.
DhillonBMcCollPLoweGDOFleckBW. Blood viscosity and retinopathy of prematurity: A preliminary report. Metabolic, Pediatr Systemic Ophthalmol1992; 15: 25–28
35.
OkadaKJikiharaSYamamotoTIchihashiHYoshidaH. Systemic factors involved in the pathogenesis and evolution of retinopathy of prematurity. Folia Ophthalmologica Japonica1993; 44: 1410–1414
36.
FauchereJMeierGibbonsFEKoernerFBossiE. Retinopathy of prematurity and bilirubin — No clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant. Eur J Pediatr1994; 153: 358–362
37.
AlonTHemoIItinAPeerJStoneJKeshetE. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Medicine1995; 1: 1024–1028